RPID has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RPID has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Gross Margin % is calculated as gross profit divided by its revenue. Rapid Micro Biosystems's Gross Profit for the three months ended in Dec. 2024 was $0.98 Mil. Rapid Micro Biosystems's Revenue for the three months ended in Dec. 2024 was $8.22 Mil. Therefore, Rapid Micro Biosystems's Gross Margin % for the quarter that ended in Dec. 2024 was 11.94%.
The historical rank and industry rank for Rapid Micro Biosystems's Gross Margin % or its related term are showing as below:
During the past 6 years, the highest Gross Margin % of Rapid Micro Biosystems was -0.39%. The lowest was -50.20%. And the median was -28.84%.
Rapid Micro Biosystems had a gross margin of 11.94% for the quarter that ended in Dec. 2024 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Rapid Micro Biosystems was 21.00% per year.
The historical data trend for Rapid Micro Biosystems's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rapid Micro Biosystems Annual Data | |||||||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||
Gross Margin % | Get a 7-Day Free Trial | -50.20 | -33.32 | -49.85 | -24.36 | -0.39 |
Rapid Micro Biosystems Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Gross Margin % | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
-2.71 | -27.14 | -2.86 | 8.18 | 11.94 |
For the Medical Devices subindustry, Rapid Micro Biosystems's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Rapid Micro Biosystems's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Rapid Micro Biosystems's Gross Margin % falls into.
Gross Margin is the percentage of Gross Profit out of sales or Revenue.
Rapid Micro Biosystems's Gross Margin for the fiscal year that ended in Dec. 2024 is calculated as
Gross Margin % (A: Dec. 2024 ) | = | Gross Profit (A: Dec. 2024 ) | / | Revenue (A: Dec. 2024 ) |
= | -0.1 | / | 28.051 | |
= | (Revenue - Cost of Goods Sold) | / | Revenue | |
= | (28.051 - 28.16) | / | 28.051 | |
= | -0.39 % |
Rapid Micro Biosystems's Gross Margin for the quarter that ended in Dec. 2024 is calculated as
Gross Margin % (Q: Dec. 2024 ) | = | Gross Profit (Q: Dec. 2024 ) | / | Revenue (Q: Dec. 2024 ) |
= | 1 | / | 8.218 | |
= | (Revenue - Cost of Goods Sold) | / | Revenue | |
= | (8.218 - 7.237) | / | 8.218 | |
= | 11.94 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Rapid Micro Biosystems (NAS:RPID) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Rapid Micro Biosystems had a gross margin of 11.94% for the quarter that ended in Dec. 2024 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Thank you for viewing the detailed overview of Rapid Micro Biosystems's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Melinda Litherland Pei | director | 1000 ALFRED NOBEL DRIVE, HERCULES CA 94547 |
Kirk Malloy | director | 5200 ILLUMINA WAY, SAN DIEGO CA 92122 |
Sean M Wirtjes | officer: Chief Financial Officer | C/O VARIAN, INC., 3120 HANSEN WAY, M/S D-083, PALO ALTO CA 94304-1030 |
Spignesi Robert G. Jr. | director, officer: President and CEO | C/O RAPID MICRO BIOSYSTEMS, INC., 1001 PAWTUCKET BOULEVARD WEST, SUITE 280, LOWELL MA 01854 |
Richard S Kollender | director | C/O QUAKER BIOVENTURES, CIRA CENTRE, 2929 ARCH STREET, 3RD FLOOR, PHILADELPHIA PA 19104-2868 |
Kennedy Lewis Capital Partners Master Fund Ii Lp | 10 percent owner | 111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120 |
Darren Richman | 10 percent owner | 80 BROAD STREET, 22ND FLOOR, NEW YORK NY 10004 |
Klm Gp Llc | 10 percent owner | 80 BROAD STREET, 22ND FLOOR, NEW YORK NY 10004 |
Kennedy Lewis Investment Management Llc | 10 percent owner | 80 BROAD STREET, 22ND FLOOR, NEW YORK NY 10004 |
Kennedy Lewis Management Lp | 10 percent owner | 225 LIBERTY STREET, SUITE 4210, NEW YORK NY 10281 |
David Chene | 10 percent owner | 80 BROAD STREET, 22ND FLOOR, NEW YORK NY 10004 |
Kennedy Lewis Capital Partners Master Fund Iii Lp | 10 percent owner | 111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120 |
Kennedy Lewis Gp Iii Llc | 10 percent owner | 111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120 |
Kennedy Lewis Investment Holdings Ii Llc | 10 percent owner | 111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120 |
Kennedy Lewis Gp Ii Llc | 10 percent owner | 111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120 |
From GuruFocus
By Marketwired • 11-08-2024
By Marketwired • 09-03-2024
By GuruFocus Research • 05-04-2024
By GuruFocus Research • 03-02-2024
By GuruFocus News • 02-27-2025
By Marketwired • 03-12-2025
By Marketwired • 02-27-2025
By GuruFocus Research • 08-03-2024
By Marketwired • 11-01-2024
By GuruFocus News • 11-02-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.